WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

Search

Afya Ltd (Class A)

Отворен

СекторДефанзивни потребителски стоки

14.57 -0.88

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

14.32

Максимум

14.75

Ключови измерители

By Trading Economics

Приходи

-13M

181M

Продажби

9.1M

929M

P/E

Средно за сектора

10.188

28.875

Дивидентна доходност

1.53

Марж на печалбата

19.455

EBITDA

-28M

397M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+30.96% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.53%

3.67%

Следващи печалби

12.03.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

64M

1.4B

Предишно отваряне

15.45

Предишно затваряне

14.57

Настроения в новините

By Acuity

100%

0%

131 / 140 Класиране в Consumer defensive

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Afya Ltd (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.01.2026 г., 22:41 ч. UTC

Придобивния, сливания и поглъщания

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15.01.2026 г., 00:00 ч. UTC

Печалби

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14.01.2026 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14.01.2026 г., 23:39 ч. UTC

Пазарно говорене

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14.01.2026 г., 23:32 ч. UTC

Пазарно говорене

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14.01.2026 г., 22:56 ч. UTC

Придобивния, сливания и поглъщания

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14.01.2026 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14.01.2026 г., 22:17 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.01.2026 г., 22:17 ч. UTC

Пазарно говорене

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14.01.2026 г., 22:09 ч. UTC

Печалби

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14.01.2026 г., 22:08 ч. UTC

Печалби

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14.01.2026 г., 22:08 ч. UTC

Печалби

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14.01.2026 г., 21:53 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14.01.2026 г., 21:53 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14.01.2026 г., 21:52 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC Announces Positive Profit Alert for 2025

14.01.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

Citigroup Acting as Financial Advisor to WuXi XDC

14.01.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC: Aims to Keep Listing Status of BioDlink

14.01.2026 г., 21:51 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Financial Services Roundup: Market Talk

14.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

14.01.2026 г., 21:49 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14.01.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14.01.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

WuXi XDC Makes Cash Offer for BioDlink International

14.01.2026 г., 21:13 ч. UTC

Пазарно говорене

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14.01.2026 г., 20:30 ч. UTC

Пазарно говорене
Печалби

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14.01.2026 г., 20:13 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14.01.2026 г., 20:08 ч. UTC

Пазарно говорене

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14.01.2026 г., 19:33 ч. UTC

Пазарно говорене

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14.01.2026 г., 19:06 ч. UTC

Пазарно говорене
Печалби

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Afya Ltd (Class A) Прогноза

Ценова цел

By TipRanks

30.96% нагоре

12-месечна прогноза

Среден 19.88 USD  30.96%

Висок 22 USD

Нисък 17.5 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Afya Ltd (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

18.968 / 19.56Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Strong Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat